Impact of Genomic Subtype on Intracranial Outcomes in Treatment-naive EGFR mutant NSCLC with Osimertinib (IGnITE)

Publication Date

2026

Content Type

article

PubMed ID:

42520966

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS